证券代码：301528 证券简称：多浦乐 公告编号：2025-030 广州多浦乐电子科技股份有限公司 关于签署《建设工程施工合同》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 广州多浦乐电子科技股份有限公司（以下简称"公司"）于 2025 年 5 月 28 日召开了第二届董事会第十八次会议、第二届监事会第十八次会 议，审议通过了《关于签署<建设工程施工合同>的议案》，为推进首次 公开发行股票募集资金投资项目——"无损检测智能化生产基地建设项 目"及"总部大楼及研发中心建设项目"（以下简称"募投项目"）的建 设，根据公司招标的结果，公司拟与广东嵘通建设工程有限公司（以下 简称"嵘通建设"）签署《广州多浦乐产业园项目建设工程施工合同》 （以下简称"《施工合同》"），约定由嵘通建设承包上述项目建设工 程，合同总金额（含税）为人民币 126,677,472.72 元，同时向董事会申 请授权公司管理层签署施工合同及后续的相关文件、审批相关款项支付、 办理并实施本项目相关的全部事宜，并对合同履行过程进行监督及管理。 根据《深圳证券交易所创业板股票上市规则》《深圳 ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-027 广州多浦乐电子科技股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 广州多浦乐电子科技股份有限公司（以下简称"公司"）2024 年年 度权益分派方案已获 2025 年 5 月 9 日召开的 2024 年年度股东大会审议 通过，现将 2024 年年度权益分派事宜公告如下： 一、股东大会审议通过权益分派方案情况 1、公司 2024 年年度权益分派方案如下：以截至 2024 年 12 月 31 日 公司总股本 61,900,000 股为基数，向全体股东每 10 股派发现金红利人 民币 1.62 元（含税），合计派发现金股利人民币 10,027,800 元（含税）。 本次利润分配公司不以资本公积金转增股本，不送红股，剩余未分配利 润滚存至下一年度。 在本次分配方案披露至实施期间，若公司总股本发生变动，公司将 按照现金分红总额不变的原则对分配比例进行调整。 2、权益分派方案披露至实施期间，公司总股本未发生变化。 3、本次实施的权益分派方案与 2024 年年 ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-026 广州多浦乐电子科技股份有限公司 关于持股 5%以上股东减持股份触及 1%整数倍 的提示性公告 持股 5%以上股东厦门融昱佳弘投资合伙企业（有限合伙）及其一致 行动人苏州融昱瑞海投资合伙企业（有限合伙）保证向本公司提供的信 息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 2025 年 5 月 20 日，持股 5%以上股东厦门融昱及其一致行动人苏州融 昱减持公司股份触及 1%整数倍，具体详见公司于 2025 年 5 月 21 日对外披 露的《关于持股 5%以上股东减持股份触及 1%整数倍的提示性公告》（公告 编号：2025-025）。 公司于近日收到持股 5%以上股东厦门融昱及其一致行动人苏州融昱 共同出具的《关于减持股份触及 1%整数倍的告知函》，现将有关情况公告 本公司及董事会全体成员保证公告内容与信息披露义务人提供的 信息一致。 广州多浦乐电子科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日在巨潮资讯网（http://www.cninfo.com.cn）对外披露了《关于持 股 5%以上股东减持股份的预披 ...

证券代码：301528 证券简称：多浦乐 公告编号：2025-025 广州多浦乐电子科技股份有限公司 关于持股 5%以上股东减持股份触及 1%整数倍 的提示性公告 持股 5%以上股东厦门融昱佳弘投资合伙企业（有限合伙）及其一致 行动人苏州融昱瑞海投资合伙企业（有限合伙）保证向本公司提供的信 息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的 信息一致。 广州多浦乐电子科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日在巨潮资讯网（http://www.cninfo.com.cn）对外披露了《关于持 股 5%以上股东减持股份的预披露公告》（公告编号：2025-020）。持有公司 股份 5%以上股东厦门融昱佳弘投资合伙企业（有限合伙）（以下简称"厦 门融昱"）及其一致行动人苏州融昱瑞海投资合伙企业（有限合伙）（以下 简称"苏州融昱"）计划在自公告披露之日起 15 个交易日后的三个月内， 以大宗交易方式合计减持公司股份不超过 3,000,000 股（即不超过公司总 股本的 4.85%）。 公司于近日收到持股 5%以上股东厦门融昱 ...

Group 1 - The Chengfei concept index declined by 1.16% as of the market close on May 20, with several stocks in the sector hitting the daily limit down, including Lijun Co. and Tongda Co. [1][2] - Among the stocks that increased, Boyun New Materials, Chengfei Integration, and Duopule saw gains of 10.01%, 7.65%, and 3.99% respectively [1][2] - The Chengfei concept sector experienced a net outflow of 2.131 billion yuan in main funds, with 30 stocks seeing net outflows, and five stocks exceeding 100 million yuan in outflows [2][3] Group 2 - Chengfei Integration led the outflow with a net outflow of 545.48 million yuan, followed by Zhonghang Chengfei and Lijun Co. with net outflows of 522.85 million yuan and 446.76 million yuan respectively [2][3] - The stocks with the highest net inflows included Boyun New Materials, Houp Co., and Duopule, with inflows of 167.42 million yuan, 35.27 million yuan, and 15.44 million yuan respectively [2][3] - The trading volume for Chengfei Integration was 29.10%, indicating significant trading activity despite the outflow [3]

证券代码：301528 证券简称：多浦乐 公告编号：2025-024 广州多浦乐电子科技股份有限公司 关于签订募集资金三方监管协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 广州多浦乐电子科技股份有限公司（以下简称"公司"）于 2025 年 4 月 18 日召开第二届董事会第十七次会议，审议通过了《关于新增设立 募集资金专项账户并授权签订募集资金专户监管协议的议案》，公司拟在 广东南粤银行股份有限公司东莞分行新增设立募集资金专项账户，用于 "无损检测智能化生产基地建设项目"的资金存储、使用和管理，同时 授权董事长或其指派的相关人员办理募集资金专用账户的开立、募集资 金三方监管协议签署等相关事项。近日，相关《募集资金三方监管协议》 已经签署完毕，具体情况如下： 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》等法律法规和公司《募 集资金管理制度》的规定，公司设立了募集资金专用账户，公司分别与 招商银行广州分行科学城支行、渤海银行股份有限公司深圳分行、平安 银行股份有限公司广州分行、中国银 ...

Core Viewpoint - The recent shareholding changes and performance decline of Duopule (301528.SZ) have raised investor concerns, particularly regarding the confidence of major shareholders in the company's future prospects [2][3][4]. Shareholder Changes - Major shareholder Cai Shuping plans to reduce his holdings by up to 1.238 million shares, representing 2% of the total share capital, within three months starting from June 4, 2025 [3][4]. - This follows a previous reduction completed in January 2025, where Cai sold 537,200 shares at an average price of 44.59 yuan per share, raising approximately 23.95 million yuan [4]. - Another significant shareholder, Xiamen Rongyu, along with its action-in-concert party Suzhou Rongyu, plans to collectively reduce their holdings by up to 3 million shares, or 4.85% of the total share capital, from May 20 to August 17, 2025 [5]. Financial Performance - Duopule's revenue for 2023 was 199 million yuan, a year-on-year decline of 1.41%, with net profit dropping by 8.88% to 77.81 million yuan [7]. - In 2024, revenue further decreased to 162 million yuan, down 18.70%, and net profit fell by 33.68% to 51.60 million yuan [7]. - The company reported a significant increase in revenue in Q1 2025, achieving 38.49 million yuan, a year-on-year growth of 125.44%, but the gross margin decreased by 6.25% [8]. Industry Context - Duopule operates in a technology-intensive sector focused on non-destructive testing equipment, which requires high levels of R&D investment to maintain competitiveness [6]. - The company invested 38.40 million yuan in R&D in 2024, a 13.94% increase from the previous year, accounting for 23.70% of its revenue [6]. - The domestic non-destructive testing equipment industry is still in a growth phase, with a domestic market penetration rate of 52% as of 2023, but high-end products are predominantly supplied by foreign companies [6][8]. Strategic Developments - Duopule is actively expanding into the medical sector, having invested in companies related to medical ultrasound technology, although these initiatives are currently in the investment phase and have not yet contributed significantly to revenue [8][9].

Group 1: International Market Expansion - The company has established a wholly-owned subsidiary in Germany to enhance its presence in the European market, with registration completed in March 2025 [2][3] - Current overseas clients include SGS, indicating ongoing international market development [2] Group 2: Financial Performance and Goals - The company's revenue for Q1 2025 reached ¥38,486,755.18, a year-on-year increase of 125.44%, while net profit grew by 266.31% [8] - In 2024, the company experienced a net profit decline of 33.68%, attributed to a slowdown in domestic economic growth and a significant drop in revenue from Russia by 73.58% [5][6] Group 3: Research and Development Investment - R&D investment in 2024 amounted to ¥38,400,000, representing 23.70% of total revenue, with a year-on-year increase of 13.94% [4][7] - The company is involved in national projects focusing on advanced ultrasonic detection systems, aiming to enhance product competitiveness [6][7] Group 4: Product Development and Market Strategy - The company has launched new products, including the Novascan V2 and Eagle 4501P, enhancing detection capabilities in various sectors [8][9] - Targeted market expansion includes sectors like rail transportation, new energy vehicles, and semiconductors, with specific products developed for these industries [6][9] Group 5: Competitive Landscape and Challenges - The ultrasonic non-destructive testing industry is facing intense competition, with the company emphasizing its technological innovation and product quality as competitive advantages [4][6] - The company acknowledges the impact of external factors such as international trade dynamics and market sentiment on stock performance [10]

Group 1 - The major shareholder Cai Shuping plans to reduce his stake in Duopule (301528.SZ) by up to 1,238,000 shares, which is 2% of the total share capital, within three months after the announcement [1] - Duopule was listed on the Shenzhen Stock Exchange's ChiNext board on August 28, 2023, with an initial issuance of 15.5 million shares, accounting for 25.04% of the total share capital, at a price of 71.80 yuan per share [1] - The stock reached a peak price of 185 yuan on its first trading day but has since experienced a decline and is currently trading below its initial offering price [1] Group 2 - Duopule raised a total of 1,112.90 million yuan in its IPO, with a net amount of 1,007.92 million yuan after deducting issuance costs, exceeding the original plan by 518.65 million yuan [2] - The funds raised are intended for the construction of a non-destructive testing intelligent production base, as well as a headquarters building and R&D center [2] - The total issuance costs (excluding VAT) amounted to 104.98 million yuan, with underwriting fees accounting for 82.52 million yuan [3]

Group 1 - Baichuan Energy plans to reduce its shareholding by up to 26.82 million shares, accounting for 2% of the total share capital, due to personal investment and funding needs [1] - Jinhong Gas intends to distribute a cash dividend of 1.00 yuan per 10 shares, with the record date on May 15, 2025 [2] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1% of the total share capital due to liquidity needs [2][3] Group 2 - Jiadu Technology will cancel 10.20 million repurchased shares, reducing its total share capital from 2.143 billion shares to 2.133 billion shares [4] - ILE Home's shareholder plans to reduce its stake by up to 154,250 shares, accounting for 0.4778% of the total share capital, due to funding needs [5] - Lai Yifen has fully removed related batches of its honey date dumpling products from shelves due to consumer health concerns [6][7] Group 3 - CATL's vice chairman Li Ping and spouse plan to donate 4.05 million shares to Fudan University for establishing a research fund, reducing Li Ping's shareholding from 4.58% to 4.48% [8] - Shuanghuan Transmission's shareholders completed their reduction plan, selling a total of 6.69 million shares, accounting for 0.789% of the total share capital [9] - Chengfei Integration reported no significant changes in its business operations or external environment despite stock price fluctuations [10] Group 4 - Guizhou Tire's controlling shareholder plans to increase its stake by no less than 50 million yuan and no more than 100 million yuan within six months [11] - *ST Youshu's application to revoke the delisting risk warning has been approved, and its stock will resume trading under a new name [13] - Jingwei Huikai's shareholders plan to reduce their stake by up to 3% of the total share capital due to funding needs [14] Group 5 - Hualan Biological's major shareholder plans to reduce its stake by up to 3% of the total share capital due to funding needs [15] - Huyou Pharmaceutical's shareholder plans to reduce its stake by up to 2.997% of the total share capital due to funding needs [16] - Dongpeng Holdings' shareholders plan to reduce their stake by up to 1.5% of the total share capital due to funding needs [17] Group 6 - Keleke's controlling shareholder plans to reduce its stake by up to 3% of the total share capital due to funding needs [18] - Dongfang Ocean's major shareholder plans to reduce its stake by 1% of the total share capital due to investor redemption requests [19] - Yisheng Shares reported a sales revenue of 141 million yuan from white feather chicken seedlings in April, with a year-on-year decrease of 7.28% [20] Group 7 - Qujiang Cultural Tourism's controlling shareholder's 12 million shares are set to be auctioned due to contractual disputes, representing 4.70% of the total share capital [21] - Duople's shareholder plans to reduce its stake by up to 123,800 shares, accounting for 2% of the total share capital, due to personal funding needs [22][23]